Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenovirus
Cidofovir effectively treats adenoviral hemorrhagic cystitis in HSCT patients
January 27th, 2005
Cidofovir effectively treats adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant patients. According to investigators in Japan, "Adenovirus (AdV) infection is an important cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) recipients. "We treated 16 patients with AdV hemorrhagic cystitis (HC) following HSCT with cidofovir (CDV; 1 mg/kg/day, 3 times weekly for 3 weeks). Patients included 10 males and six females with a median age of 50 years (range 10-62)." "Two of the 16 patients were unevaluable because of early death from nonadenoviral causes. CDV therapy cleared AdV from urine in 12...
Source: Women's Health Weekly (2005-01-27)
|
